The final, formatted version of the article will be published soon.
SYSTEMATIC REVIEW article
Front. Microbiol.
Sec. Systems Microbiology
Volume 15 - 2024 |
doi: 10.3389/fmicb.2024.1387679
Oropharyngeal Cancer and Human Papillomavirus: A visualization based on bibliometrics and topic modeling
Provisionally accepted- 1 Department of Head and Neck Surgery, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
- 2 Department of Abdominal·Osteomalacia Radiotherapy, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
- 3 Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China
The incidence of oropharyngeal cancer (OPC) is increasing. This study used bibliometric analysis and topic modeling to explore the research trends and advancements in this disease over the past ten years, providing valuable insights to guide future investigations. Methods: 7,355 English articles from 2013-2022 were retrieved from the Web of Science Core Collection for bibliometric analysis. Topic modeling was applied to 1,681 articles from high-impact journals, followed by an assessment of topic significance ranking (TSR). Medical Subject Headings (MeSH) terms were extracted using R and Python, followed by an analysis of the terms associated with each topic and on an annual basis. Additionally, genes were extracted and the number of genes appearing each year and the newly emerged genes were counted.The bibliometric analysis suggested that the United States and several European countries hold pivotal positions in research. Current research is focused on refining treatments, staging and stratification. Topic modeling revealed 12 topics, emphasizing human papillomavirus (HPV) and side effect reduction. MeSH analysis revealed a growing emphasis on prognosis and quality of life. No new MeSH terms emerged after 2018, suggesting that the existing terms have covered most of the core concepts within the field of oropharyngeal cancers. Gene analysis identified TP53 and EGFR as the most extensively studied genes, with no novel genes discovered after 2019.However, CD69 and CXCL9 emerged as new genes of interest in 2019, reflecting recent research trends and directions.HPV-positive oropharyngeal cancer research, particularly treatment deescalation, has gained significant attention. However, there are still challenges in diagnosis and treatment that need to be addressed. In the future, more research will focus on this issue, indicating that this field still holds potential as a research hotspot.
Keywords: oropharyngeal cancer, HPV, treatment strategies, Topic Modeling, bibliometric analysis
Received: 18 Feb 2024; Accepted: 30 Apr 2024.
Copyright: © 2024 Liu, Wang, Xu, Wei, Zhang and Dong. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Haixu Wang, Department of Abdominal·Osteomalacia Radiotherapy, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
Yang Xu, Department of Head and Neck Surgery, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
Hongming Wei, Department of Head and Neck Surgery, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
Yuchong Zhang, Department of Medical Oncology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China
Huilei Dong, Department of Head and Neck Surgery, Cancer hospital of China Medical University/Liaoning Cancer hospital & Institute, Shenyang, Liaoning Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.